Rakovina Therapeutics Inc (RKV.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 756 | 690 | 661 | 590 | 585 |
| Operating Income | -756 | -690 | -661 | -590 | -585 |
| Interest Expense | 66 | 65 | 65 | 64 | 22 |
| Other Income | 2 | 3 | 4 | 7 | 6 |
| Pre-tax Income | -821 | -752 | -723 | -647 | -601 |
| Net Income Continuous | -821 | -752 | -723 | -647 | -601 |
| Net Income | $-821 | $-752 | $-723 | $-647 | $-601 |
| EPS Basic Total Ops | -0.10 | -0.10 | -0.10 | -0.10 | -0.10 |
| EPS Basic Continuous Ops | -0.10 | -0.10 | -0.10 | -0.10 | -0.10 |
| EPS Diluted Total Ops | -0.10 | -0.10 | -0.10 | -0.10 | -0.10 |
| EPS Diluted Continuous Ops | -0.10 | -0.10 | -0.10 | -0.10 | -0.10 |
| EBITDA(a) | $-621 | $-553 | $-523 | $-448 | $-446 |